241 related articles for article (PubMed ID: 15913605)
1. Layilin, a cell surface hyaluronan receptor, interacts with merlin and radixin.
Bono P; Cordero E; Johnson K; Borowsky M; Ramesh V; Jacks T; Hynes RO
Exp Cell Res; 2005 Aug; 308(1):177-87. PubMed ID: 15913605
[TBL] [Abstract][Full Text] [Related]
2. Expression level, subcellular distribution and rho-GDI binding affinity of merlin in comparison with Ezrin/Radixin/Moesin proteins.
Maeda M; Matsui T; Imamura M; Tsukita S; Tsukita S
Oncogene; 1999 Aug; 18(34):4788-97. PubMed ID: 10490812
[TBL] [Abstract][Full Text] [Related]
3. Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin.
Shaw RJ; McClatchey AI; Jacks T
Cell Growth Differ; 1998 Apr; 9(4):287-96. PubMed ID: 9563848
[TBL] [Abstract][Full Text] [Related]
4. Insights into a single rod-like helix in activated radixin required for membrane-cytoskeletal cross-linking.
Hoeflich KP; Tsukita S; Hicks L; Kay CM; Tsukita S; Ikura M
Biochemistry; 2003 Oct; 42(40):11634-41. PubMed ID: 14529273
[TBL] [Abstract][Full Text] [Related]
5. Analysis of molecular domains of epitope-tagged merlin isoforms in Cos-7 cells and primary rat Schwann cells.
Xu L; Gonzalez-Agosti C; Beauchamp R; Pinney D; Sterner C; Ramesh V
Exp Cell Res; 1998 Jan; 238(1):231-40. PubMed ID: 9457076
[TBL] [Abstract][Full Text] [Related]
6. Detection of cellular proteins that interact with the NF2 tumor suppressor gene product.
Takeshima H; Izawa I; Lee PS; Safdar N; Levin VA; Saya H
Oncogene; 1994 Aug; 9(8):2135-44. PubMed ID: 8035998
[TBL] [Abstract][Full Text] [Related]
7. Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2.
Wiederhold T; Lee MF; James M; Neujahr R; Smith N; Murthy A; Hartwig J; Gusella JF; Ramesh V
Oncogene; 2004 Nov; 23(54):8815-25. PubMed ID: 15467741
[TBL] [Abstract][Full Text] [Related]
8. Radixin: cytoskeletal adopter and signaling protein.
Hoeflich KP; Ikura M
Int J Biochem Cell Biol; 2004 Nov; 36(11):2131-6. PubMed ID: 15313460
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of ezrin/radixin/moesin (ERM) and ERM-associated adhesion molecules in the blastocyst and uterus suggests their functions during implantation.
Matsumoto H; Daikoku T; Wang H; Sato E; Dey SK
Biol Reprod; 2004 Mar; 70(3):729-36. PubMed ID: 14613898
[TBL] [Abstract][Full Text] [Related]
10. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
[TBL] [Abstract][Full Text] [Related]
11. DCC regulates cell adhesion in human colon cancer derived HT-29 cells and associates with ezrin.
MartÃn M; Simon-Assmann P; Kedinger M; Martin M; Mangeat P; Real FX; Fabre M
Eur J Cell Biol; 2006 Aug; 85(8):769-83. PubMed ID: 16762451
[TBL] [Abstract][Full Text] [Related]
12. Layilin, a novel integral membrane protein, is a hyaluronan receptor.
Bono P; Rubin K; Higgins JM; Hynes RO
Mol Biol Cell; 2001 Apr; 12(4):891-900. PubMed ID: 11294894
[TBL] [Abstract][Full Text] [Related]
13. Quinocarmycin analog DX-52-1 inhibits cell migration and targets radixin, disrupting interactions of radixin with actin and CD44.
Kahsai AW; Zhu S; Wardrop DJ; Lane WS; Fenteany G
Chem Biol; 2006 Sep; 13(9):973-83. PubMed ID: 16984887
[TBL] [Abstract][Full Text] [Related]
14. Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway.
Hirao M; Sato N; Kondo T; Yonemura S; Monden M; Sasaki T; Takai Y; Tsukita S; Tsukita S
J Cell Biol; 1996 Oct; 135(1):37-51. PubMed ID: 8858161
[TBL] [Abstract][Full Text] [Related]
15. Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells.
Lallemand D; Saint-Amaux AL; Giovannini M
J Cell Sci; 2009 Nov; 122(Pt 22):4141-9. PubMed ID: 19910496
[TBL] [Abstract][Full Text] [Related]
16. Subcellular localization and expression pattern of the neurofibromatosis type 2 protein merlin/schwannomin.
Schmucker B; Ballhausen WG; Kressel M
Eur J Cell Biol; 1997 Jan; 72(1):46-53. PubMed ID: 9013725
[TBL] [Abstract][Full Text] [Related]
17. Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP.
Nguyen R; Reczek D; Bretscher A
J Biol Chem; 2001 Mar; 276(10):7621-9. PubMed ID: 11106646
[TBL] [Abstract][Full Text] [Related]
18. ERM-Merlin and EBP50 protein families in plasma membrane organization and function.
Bretscher A; Chambers D; Nguyen R; Reczek D
Annu Rev Cell Dev Biol; 2000; 16():113-43. PubMed ID: 11031232
[TBL] [Abstract][Full Text] [Related]
19. Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.
Morrison H; Sperka T; Manent J; Giovannini M; Ponta H; Herrlich P
Cancer Res; 2007 Jan; 67(2):520-7. PubMed ID: 17234759
[TBL] [Abstract][Full Text] [Related]
20. The merlin tumor suppressor localizes preferentially in membrane ruffles.
Gonzalez-Agosti C; Xu L; Pinney D; Beauchamp R; Hobbs W; Gusella J; Ramesh V
Oncogene; 1996 Sep; 13(6):1239-47. PubMed ID: 8808698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
